ArticleJAMA neurology2016

Combined Plasma and Cerebrospinal Fluid Signature for the Prediction of Midterm Progression From Mild Cognitive Impairment to Alzheimer Disease.

Benoit Lehallier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.